225 related articles for article (PubMed ID: 25646705)
21. ¹⁸F-fluoride PET/CT for assessing bone involvement in prostate and breast cancers.
Withofs N; Grayet B; Tancredi T; Rorive A; Mella C; Giacomelli F; Mievis F; Aerts J; Waltregny D; Jerusalem G; Hustinx R
Nucl Med Commun; 2011 Mar; 32(3):168-76. PubMed ID: 21076343
[TBL] [Abstract][Full Text] [Related]
22. Inter- and intraobserver agreement in standard and ultra-fast single-photon emission computed tomography/computed tomography for the assessment of bone metastases.
Zacho HD; Aleksyniene R; Ejlersen JA; Fledelius J; Petersen LJ
Nucl Med Commun; 2020 Oct; 41(10):1005-1009. PubMed ID: 32694282
[TBL] [Abstract][Full Text] [Related]
23. [Detection of bone metastasis of prostate cancer - comparison of whole-body MRI and bone scintigraphy].
Ketelsen D; Röthke M; Aschoff P; Merseburger AS; Lichy MP; Reimold M; Claussen CD; Schlemmer HP
Rofo; 2008 Aug; 180(8):746-52. PubMed ID: 18512192
[TBL] [Abstract][Full Text] [Related]
24. Is bone scintigraphy necessary in initial staging of prostate cancer patients?
Jaukovic L; Adjinovic B; Cerovic S; Joksimovic M; Soldatovic Z
Hell J Nucl Med; 2011; 14(2):126-30. PubMed ID: 21761013
[TBL] [Abstract][Full Text] [Related]
25. [The indication of bone scan for patients with newly diagnosed prostate cancer].
Liu D; Wang W; Qiao LD; Zheng YP; Liu YX; Zhang GY; Chen S
Zhonghua Wai Ke Za Zhi; 2012 May; 50(5):443-5. PubMed ID: 22883953
[TBL] [Abstract][Full Text] [Related]
26. Anatomical distribution and sclerotic activity of bone metastases from thyroid cancer assessed with F-18 sodium fluoride positron emission tomography.
Schirrmeister H; Buck A; Guhlmann A; Reske SN
Thyroid; 2001 Jul; 11(7):677-83. PubMed ID: 11484897
[TBL] [Abstract][Full Text] [Related]
27. Whole-body 3D T1-weighted MR imaging in patients with prostate cancer: feasibility and evaluation in screening for metastatic disease.
Pasoglou V; Michoux N; Peeters F; Larbi A; Tombal B; Selleslagh T; Omoumi P; Vande Berg BC; Lecouvet FE
Radiology; 2015 Apr; 275(1):155-66. PubMed ID: 25513855
[TBL] [Abstract][Full Text] [Related]
28. Comparison of 18F fluoride PET/CT and 99mTc-MDP bone scan in the detection of skeletal metastases in urinary bladder carcinoma.
Chakraborty D; Bhattacharya A; Mete UK; Mittal BR
Clin Nucl Med; 2013 Aug; 38(8):616-21. PubMed ID: 23603596
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of osseous metastasis in bone scintigraphy.
Davila D; Antoniou A; Chaudhry MA
Semin Nucl Med; 2015 Jan; 45(1):3-15. PubMed ID: 25475375
[TBL] [Abstract][Full Text] [Related]
30. Comparison of FDG-PET/CT and bone scintigraphy for detection of bone metastases in breast cancer.
Hahn S; Heusner T; Kümmel S; Köninger A; Nagarajah J; Müller S; Boy C; Forsting M; Bockisch A; Antoch G; Stahl A
Acta Radiol; 2011 Nov; 52(9):1009-14. PubMed ID: 21969709
[TBL] [Abstract][Full Text] [Related]
31. [18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients.
Poulsen MH; Bouchelouche K; Høilund-Carlsen PF; Petersen H; Gerke O; Steffansen SI; Marcussen N; Svolgaard N; Vach W; Geertsen U; Walter S
BJU Int; 2012 Dec; 110(11):1666-71. PubMed ID: 22520686
[TBL] [Abstract][Full Text] [Related]
32. Three-minute SPECT/CT is sufficient for the assessment of bone metastasis as add-on to planar bone scintigraphy: prospective head-to-head comparison to 11-min SPECT/CT.
Zacho HD; Manresa JAB; Aleksyniene R; Ejlersen JA; Fledelius J; Bertelsen H; Petersen LJ
EJNMMI Res; 2017 Dec; 7(1):1. PubMed ID: 28058659
[TBL] [Abstract][Full Text] [Related]
33. Comparison of (18)F-FDG-PET/CT with (99m)Tc-MDP bone scintigraphy for the detection of bone metastases in cancer patients.
Ozülker T; Küçüköz Uzun A; Ozülker F; Ozpaçac T
Nucl Med Commun; 2010 Jun; 31(6):597-603. PubMed ID: 20224457
[TBL] [Abstract][Full Text] [Related]
34. Higher scrotal uptake ratio of (99m)Tc-MDP on bone scans in newly diagnosed prostate cancer: a reliable indicator of pelvic node metastasis.
Zaman MU; Fatima N; Sajjad Z; Hashmi I; Khan K
Ann Nucl Med; 2012 Oct; 26(8):676-80. PubMed ID: 22777858
[TBL] [Abstract][Full Text] [Related]
35. 99mTc-Methylene diphosphonate SPECT/CT as the one-stop imaging modality for the diagnosis of osteoid osteoma.
Sharma P; Mukherjee A; Karunanithi S; Nadarajah J; Gamanagatti S; Khan SA; Bal C; Kumar R
Nucl Med Commun; 2014 Aug; 35(8):876-83. PubMed ID: 24751704
[TBL] [Abstract][Full Text] [Related]
36. Whole-body diffusion-weighted MRI compared with (18)F-NaF PET/CT for detection of bone metastases in patients with high-risk prostate carcinoma.
Mosavi F; Johansson S; Sandberg DT; Turesson I; Sörensen J; Ahlström H
AJR Am J Roentgenol; 2012 Nov; 199(5):1114-20. PubMed ID: 23096187
[TBL] [Abstract][Full Text] [Related]
37. Comparative study of whole-body MRI and bone scintigraphy for the detection of bone metastases.
Balliu E; Boada M; Peláez I; Vilanova JC; Barceló-Vidal C; Rubio A; Galofré P; Castro A; Pedraza S
Clin Radiol; 2010 Dec; 65(12):989-96. PubMed ID: 21070903
[TBL] [Abstract][Full Text] [Related]
38. Development of Convolutional Neural Networks to identify bone metastasis for prostate cancer patients in bone scintigraphy.
Papandrianos N; Papageorgiou EI; Anagnostis A
Ann Nucl Med; 2020 Nov; 34(11):824-832. PubMed ID: 32839920
[TBL] [Abstract][Full Text] [Related]
39. [Paget's disease mimicking metastatic prostate cancer on bone scan image : a case report].
Fukushi K; Koie T; Yamamoto H; Okamoto A; Imai A; Hatakeyama S; Yoneyama T; Hashimoto Y; Ohyama C
Hinyokika Kiyo; 2013 Apr; 59(4):247-50. PubMed ID: 23635462
[TBL] [Abstract][Full Text] [Related]
40. Bone marrow scintigraphy in prostatic carcinomas.
Bourgeois P; Malarme M; Van Franck R; Wauters G; Ferremans W
Nucl Med Commun; 1991 Jan; 12(1):35-45. PubMed ID: 2023692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
